http://www.zibb.com/all/theme/cq/Generex+Biotechnology+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Mon, 23 Nov 2009 15:47:23 GMTMon, 23 Nov 2009 15:47:23 GMT608831http://www.zibb.com/all/theme/cq/Generex+Biotechnology+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://finance.yahoo.com/news/Generex-Scientist-Makes-pz-338098453.html?x=0&.v=1WORCESTER, Mass., Nov. 23, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT - News) (www.generex.com) announced today that Dr. Douglas Powell, Director of Immunobiology at Antigenhttp://finance.yahoo.com/news/Generex-Scientist-Makes-pz-338098453.html?x=0&.v=1Generex Biotechnology CorporationMon, 23 Nov 2009 15:47:23 GMThttp://www.zibb.com/article/5683925/Ridgewater+Equity+Trend+and+Financial+Analysis+of+Generex+Biotechnology+Corp+Allscripts+Misys+Healthcare+Solutions+Inc+Lexicon+Pharmaceuticals+Inc+ATP+Oil+Gas+Corp+TeleCommunication+Systems+Inc+and+Charming+Shoppes+IncSeven of ten sectors ended in the red today led by technology, utilities and industrial sectors. Financial, healthcare and telecom sectors were the ones to end in the green. The financial sector was mainly led by the banks. Ridgewater Equity has recently begun technical fundamental analysishttp://www.zibb.com/article/5683925/Ridgewater+Equity+Trend+and+Financial+Analysis+of+Generex+Biotechnology+Corp+Allscripts+Misys+Healthcare+Solutions+Inc+Lexicon+Pharmaceuticals+Inc+ATP+Oil+Gas+Corp+TeleCommunication+Systems+Inc+and+Charming+Shoppes+IncGenerex Biotechnology CorporationFri, 20 Nov 2009 08:10:55 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3498627&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3498627&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2280330638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3498627&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3498627&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2280330638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenerex Biotechnology CorporationThu, 22 Oct 2009 08:44:47 GMThttp://www.biospace.com/news_story.aspx?StoryID=154677&full=1"We feel that the establishment of this subsidiary will allow the company to untap a part of the world where governments are eager to implement new treatments to growing pandemics both in diabetes and influenzas," stated Anna Gluskin, Generex's President and Chief Executive Officer.http://www.biospace.com/news_story.aspx?StoryID=154677&full=1Generex Biotechnology CorporationWed, 02 Sep 2009 12:00:00 GMThttp://biz.yahoo.com/pz/090112/157492.htmlGenerex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Studies. - WORCESTER, Mass., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com) announced today the publication of a report reviewing the studieshttp://biz.yahoo.com/pz/090112/157492.htmlGenerex Biotechnology CorporationMon, 12 Jan 2009 14:30:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/Generex-Biotechnology-pz-13416118.htmlA joint panel of ADA and EASD experts updated the treatment recommendations for Type 2 diabetes in a consensus statement which provides guidance to health care providers. The algorithm describes a stepped-care approach to treat the elevated blood glucose levels that characterize diabetes.http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/Generex-Biotechnology-pz-13416118.htmlGenerex Biotechnology CorporationThu, 30 Oct 2008 13:00:00 GMThttp://seekingalpha.com/article/72128-oral-insulin-balancing-safety-with-efficacy?source=feedR.J Steffens submits:In the April issue of Diabetes Care, the long running "Atherosclerosis Risk in Communities" [ARIC] study led by Frederick Brancati, M.D., of Johns Hopkins, found that lung function declines faster in type 2 diabetes patients than in those withouthttp://seekingalpha.com/article/72128-oral-insulin-balancing-safety-with-efficacy?source=feedGenerex Biotechnology CorporationMon, 14 Apr 2008 06:39:15 GMThttp://www.marketwatch.com/news/story/drug-stocks-slide-mannkind-alkermes/story.aspx?guid=%7B5DBDCD6F-B996-41C5-A9B1-5DE24566A0FE%7DDrug stocks fall as shares of Mannkind and Alkermes slide on news that Alkermes' partner, Eli Lilly, has pulled out of a pact to develop an inhaled insulin product.http://www.marketwatch.com/news/story/drug-stocks-slide-mannkind-alkermes/story.aspx?guid=%7B5DBDCD6F-B996-41C5-A9B1-5DE24566A0FE%7DGenerex Biotechnology CorporationMon, 10 Mar 2008 19:49:16 GMThttp://www.genengnews.com/news/bnitem.aspx?name=5698900Generex Biotechnology reports that Cardinal Health will distribute its new Glucose RapidSpray™ product in the U.S. The product is an alternative for people who require or want addihttp://www.genengnews.com/news/bnitem.aspx?name=5698900Generex Biotechnology Corporationhttp://www.generex.com/press_release_desc.php?id=51&year=(http://www.abptrade.com.br) for the registration, importation, marketing, distribution, and sale in Brazil of Glucose RapidSpray(tm) (http://www.glucoserapidspray.com), the Company's proprietary glucose buccal spray product.http://www.generex.com/press_release_desc.php?id=51&year=Generex Biotechnology Corporationhttp://topics.nytimes.com/top/news/business/companies/generex-biotechnology-corporation/index.htmlEli Lilly & Co, one of the world's top sellers of diabetes medicines, says it will work with Generex Biotechnology Corp to try to develop form of insulin that can be taken orallyhttp://topics.nytimes.com/top/news/business/companies/generex-biotechnology-corporation/index.htmlGenerex Biotechnology Corporationhttp://www.packagingtoday.co.uk/story.asp?storycode=33179Canadian buccal delivery specialist Generex Biotechnology Corporation says that Oral-lyn, its proprietary oral insulin spray formulation, has been approved for commercial marketing and sale by the Ecuadorian Ministry of Public Health for the treatment of both Type-1 and Type-2 diabetes.http://www.packagingtoday.co.uk/story.asp?storycode=33179Generex Biotechnology Corporationhttp://www.datamonitor.com/industries/news/article/?pid=4577BE29-5EA8-4277-BF93-19F4BD735969&type=NewsWireThe Australian Patent Office has granted the company a patent that contains formulation and method claims to a pharmaceutical formulation comprising a macromolecular pharmaceutical agent in mixed micellar form, and metered dose device containing said formulation, for buccal administration.http://www.datamonitor.com/industries/news/article/?pid=4577BE29-5EA8-4277-BF93-19F4BD735969&type=NewsWireGenerex Biotechnology Corporationhttp://pharmabioingredients.com/news/2005/02/10/generex_biotechnology_to_develop_small_pox_vaccineGenerex Biotechnology Corporation announced today that its wholly owned subsidiary, Antigen Express, has established collaborations with Emory University and the Imperial College of London to develop a novel smallpox vaccine.http://pharmabioingredients.com/news/2005/02/10/generex_biotechnology_to_develop_small_pox_vaccineGenerex Biotechnology Corporationhttp://www.newsrx.com/newsletters/Vaccine-Weekly/2007-05-16/42051620076VW.htmlThe Company plans to complete patient reporting in July, report the results over the following 2 months, and submit an IND for Lovaxin C to the FDA by October, 2007. If the IND is approved, it would be...http://www.newsrx.com/newsletters/Vaccine-Weekly/2007-05-16/42051620076VW.htmlGenerex Biotechnology Corporationhttp://finance.yahoo.com/news/Generex-Announces-That-It-pz-2723376485.html?x=0&.v=1WORCESTER, Mass., Oct. 29, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT - News) (www.generex.com), the leader in drug delivery for metabolic diseases through the innerhttp://finance.yahoo.com/news/Generex-Announces-That-It-pz-2723376485.html?x=0&.v=1Generex Biotechnology CorporationThu, 29 Oct 2009 22:25:12 GMThttp://www.zibb.com/article/5606272/Generex+Biotechnology+Receives+Purchase+Order+for+Generex+Oral+lyn+TM+for+Algerian+MarketGenerex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced it has received its first purchase order for Generex Oral-lyn(TM) from Continental Pharm Laboratories, a pharmaceuticalhttp://www.zibb.com/article/5606272/Generex+Biotechnology+Receives+Purchase+Order+for+Generex+Oral+lyn+TM+for+Algerian+MarketGenerex Biotechnology CorporationWed, 21 Oct 2009 09:30:50 GMThttp://finance.yahoo.com/news/Generex-Going-Concern-pz-339139263.html?x=0&.v=1WORCESTER, Mass., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Pursuant to Nasdaq Marketplace Rule 5250(b)(2), Generex Biotechnology Corporation (Nasdaq:GNBT - News) (www.generex.com) today announced that its consolidatedhttp://finance.yahoo.com/news/Generex-Going-Concern-pz-339139263.html?x=0&.v=1Generex Biotechnology CorporationTue, 20 Oct 2009 20:00:00 GMThttp://www.zibb.com/article/5595881/Generex+Launches+Generex+Oral+lyn+TM+in+AlgeriaGenerex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that, at a conference earlier this week in Oran, Algeria, Generex, together with Continental Pharma Laboratories, thehttp://www.zibb.com/article/5595881/Generex+Launches+Generex+Oral+lyn+TM+in+AlgeriaGenerex Biotechnology CorporationFri, 16 Oct 2009 09:30:33 GMThttp://biz.yahoo.com/pz/081211/156236.htmlGenerex Biotechnology Update On Novel Immunotherapeutic Vaccine to be Presented At San Antonio Breast Cancer Symposium. - WORCESTER, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com) announced today that further results fromhttp://biz.yahoo.com/pz/081211/156236.htmlGenerex Biotechnology CorporationThu, 11 Dec 2008 15:03:49 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/081030/153445.htmlGenerex Biotechnology Comments On New ADA/EASD Consensus Algorithm for Type 2 Diabetes Treatment. - WORCESTER, Mass., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com), the leader in drug delivery for metabolic diseases through thehttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/081030/153445.htmlGenerex Biotechnology CorporationThu, 30 Oct 2008 13:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/Generex-to-Host-Satellite-Symposium-At-World-Congress-pz-13401938.htmlGenerex's satellite symposium, entitled Innovations in Insulin Delivery for Postprandial Glucose Control, will take place on October 30, 2008 from 14:00 to 16:00 CET in Mare Nostrum A, B, C - Rey Juan Carlos Hotel.http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/Generex-to-Host-Satellite-Symposium-At-World-Congress-pz-13401938.htmlGenerex Biotechnology CorporationWed, 29 Oct 2008 13:00:00 GMThttp://biz.yahoo.com/pz/081023/152763.htmlGenerex Biotechnology Granted Additional Time to Comply With Nasdaq Marketplace Rule 4310(c)(4). - WORCESTER, Mass., Oct. 23, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com), the leader in drug delivery for metabolic diseases through thehttp://biz.yahoo.com/pz/081023/152763.htmlGenerex Biotechnology CorporationThu, 23 Oct 2008 13:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=98660&full=1WORCESTER, Mass., June 3, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com) presented final results of the Phase I trial of the Company's novel AE37 immunotherapeutic vaccine in breast cancer patients at the 44th annual meeting of thehttp://www.biospace.com/news_story.aspx?StoryID=98660&full=1Generex Biotechnology CorporationTue, 03 Jun 2008 12:00:00 GMThttp://seekingalpha.com/article/71922-mannkind-no-partnership-likely-for-inhalable-insulin?source=yahooThere's a plethora of stuff to blog about: the Takeda-Millennium (MLNM) deal, more commentary about Merck (MRK) and Schering-Plough (SGP) and the extent of the Vytorin/Zetia fallout, Genentech's (DNA) biotech bellweather earnings after the closing bell today, just to name a few.http://seekingalpha.com/article/71922-mannkind-no-partnership-likely-for-inhalable-insulin?source=yahooGenerex Biotechnology CorporationFri, 11 Apr 2008 06:58:44 GMT